Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Nanne Croles

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
European Journal of Internal Medicine|January 29, 2019
Risk of bleeding in hospitalized patients on anticoagulant therapy: Prevalence and potential risk factorsAlbert R Dreijer, Jeroen Diepstraten, Rolf Brouwer, et al.
Plos One|June 26, 2020
Effect of antithrombotic stewardship on the efficacy and safety of antithrombotic therapy during and after hospitalizationAlbert R Dreijer, Marieke J H A Kruip, Jeroen Diepstraten, et al.
Blood Advances|December 23, 2021
COVID-19 vaccination in patients with immune thrombocytopeniaChantal Visser, Maurice Swinkels, Erik D van Werkhoven, et al.
Scientific Reports|March 26, 2025
Assessing differential application of thromboprophylaxis regimes related to risk of pulmonary embolism and mortality in COVID-19 patients through instrumental variable analysisLinda Nab, Chantal Visser, Bas C T van Bussel, et al.
The European Respiratory Journal|April 20, 2023
Chronic thromboembolic pulmonary hypertension and clot resolution after COVID-19-associated pulmonary embolismCindy M M de Jong, Chantal Visser, Remy H H Bemelmans, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
European Journal of Internal Medicine|January 29, 2019
Risk of bleeding in hospitalized patients on anticoagulant therapy: Prevalence and potential risk factorsAlbert R Dreijer, Jeroen Diepstraten, Rolf Brouwer, et al.
Plos One|June 26, 2020
Effect of antithrombotic stewardship on the efficacy and safety of antithrombotic therapy during and after hospitalizationAlbert R Dreijer, Marieke J H A Kruip, Jeroen Diepstraten, et al.
Blood Advances|December 23, 2021
COVID-19 vaccination in patients with immune thrombocytopeniaChantal Visser, Maurice Swinkels, Erik D van Werkhoven, et al.
Scientific Reports|March 26, 2025
Assessing differential application of thromboprophylaxis regimes related to risk of pulmonary embolism and mortality in COVID-19 patients through instrumental variable analysisLinda Nab, Chantal Visser, Bas C T van Bussel, et al.
The European Respiratory Journal|April 20, 2023
Chronic thromboembolic pulmonary hypertension and clot resolution after COVID-19-associated pulmonary embolismCindy M M de Jong, Chantal Visser, Remy H H Bemelmans, et al.
Pageof 2